Literature DB >> 15246688

Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling.

Karen Mellodew1, Ralf Suhr, Dafe A Uwanogho, Iris Reuter, Urban Lendahl, Helen Hodges, Jack Price.   

Abstract

Neural stem cells (NSCs) are believed to repair brain damage primarily through cell replacement: i.e., the ability to regenerate lost neurons and glia in a site-specific fashion. The neural stem cell line, MHP36, has been shown to have this capacity, but we have little idea of the molecular mechanisms that control the differentiation of such cells during brain repair. In this study we show that an early event in the differentiation of MHP36 cells, both in vivo and in vitro, is the loss of expression of the intermediate filament protein, nestin. We use a co-culture assay to show that loss of nestin is fast, being detectable after just 1 h and complete in 4 h, and is controlled by proteasome degradation rather than down-regulation of de novo nestin synthesis. We also show that nestin loss is regulated by Notch, and mediated by cell contact.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246688     DOI: 10.1016/j.devbrainres.2004.03.018

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  17 in total

1.  Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.

Authors:  Karina Kristoffersen; Mette Villingshøj; Hans Skovgaard Poulsen; Marie-Thérése Stockhausen
Journal:  Cancer Biol Ther       Date:  2013-05-10       Impact factor: 4.742

2.  mSEL-1L (Suppressor/enhancer Lin12-like) protein levels influence murine neural stem cell self-renewal and lineage commitment.

Authors:  Marina Cardano; Giuseppe R Diaferia; Monica Cattaneo; Sara S Dessì; Qiaoming Long; Luciano Conti; Pasquale Deblasio; Elena Cattaneo; Ida Biunno
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

3.  Distinct profiles of REST interactions with its target genes at different stages of neuronal development.

Authors:  Yuh-Man Sun; Deborah J Greenway; Rory Johnson; Miyoko Street; Nikolai D Belyaev; Jim Deuchars; Thomas Bee; Sandra Wilde; Noel J Buckley
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

Review 4.  Stem cell markers in gliomas.

Authors:  Paola Dell'Albani
Journal:  Neurochem Res       Date:  2008-05-21       Impact factor: 3.996

5.  In vivo imaging, tracking, and targeting of cancer stem cells.

Authors:  Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

Review 6.  Emerging role of Notch in stem cells and cancer.

Authors:  Zhiwei Wang; Yiwei Li; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-11-20       Impact factor: 8.679

7.  A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.

Authors:  Litian Yu; Patricia A Baxter; Horatiu Voicu; Sivashankarappa Gurusiddappa; Yijue Zhao; Adekunle Adesina; Tsz-Kwong Man; Qin Shu; Yu-Jing Zhang; Xiu-Mei Zhao; Jack M Su; Lazlo Perlaky; Robert Dauser; Murali Chintagumpala; Ching C Lau; Susan M Blaney; Pulivarthi H Rao; Hon-Chiu Eastwood Leung; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

Review 8.  T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.

Authors:  A E Albers; L Strauss; T Liao; T K Hoffmann; A M Kaufmann
Journal:  Clin Dev Immunol       Date:  2010-12-27

9.  GFAPδ expression in glia of the developmental and adolescent mouse brain.

Authors:  Carlyn Mamber; Willem Kamphuis; Nina L Haring; Nuzrat Peprah; Jinte Middeldorp; Elly M Hol
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  A quest for initiating cells of head and neck cancer and their treatment.

Authors:  Chao Chen; Beate Köberle; Andreas M Kaufmann; Andreas E Albers
Journal:  Cancers (Basel)       Date:  2010-07-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.